Corteva

Corteva Reports Third Quarter 2025 Results, Raises Guidance, and Details 2026 Separation Plan

Corteva reported Q1 2025 net sales of $4.42 billion, with organic sales increasing by 3% year-over-year.

Read More

AgZen Partners with Corteva To Explore Commercial Potential of RealCoverage Technology

AgZen bags a $10M Series A funding round, led by DCVC Bio alongside Material Impact, which had previously led the company’s $3.5M seed round

Read More

Profluent Bio Partners with Corteva to Advance AI-Driven Gene Editing for Sustainable Crops

Key Takeaways: Profluent Bio and Corteva announce a strategic collaboration in AI-based protein and genome design Partnership integrates Profluent’s generative biology models with Corteva’s Catalyst and Genlytix™ platforms Focused on […]

Read More